Stocks · Health care · Pharmaceutical Preparations

Vera Therapeutics, Inc.

VERA Clue Score36
United States Fiscal year ends December CIK 0001831828 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Marshall Fordyce
7 Jul 2026
President and CEO
Sold on a plan
2,200
$43.59
$95.91K
Marshall Fordyce
7 Jul 2026
President and CEO
Sold on a plan
10,500
$42.86
$450.01K
Marshall Fordyce
7 Jul 2026
President and CEO
Sold on a plan
32,550
$42.07
$1.37M
Marshall Fordyce
7 Jul 2026
President and CEO
Sold on a plan
1,000
$40.78
$40.78K
Marshall Fordyce
23 Jun 2026
President and CEO
Sold on a plan
88
$38.43
$3.38K
Marshall Fordyce
23 Jun 2026
President and CEO
Sold on a plan
18,412
$37.93
$698.39K
Marshall Fordyce
12 May 2026
President and CEO
Sold on a plan
4,281
$37.09
$158.77K
Marshall Fordyce
12 May 2026
President and CEO
Sold on a plan
14,219
$36.64
$520.98K
Marshall Fordyce
14 Apr 2026
President and CEO
Sold on a plan
900
$45.51
$40.96K
Marshall Fordyce
14 Apr 2026
President and CEO
Sold on a plan
7,921
$44.58
$353.11K
Marshall Fordyce
14 Apr 2026
President and CEO
Sold on a plan
14,130
$43.66
$616.99K

What was left out

Form 4 filings counted 40
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 11
Sales straight out of an exercise 5
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 373,190
History held since 17 May 2021